INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 15, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 617
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 192,308 | -- | 192,308 |
| Sep 02, 2011 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 35,968 | $60.35 | 193,074 |
| Jul 12, 2011 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 15,602 | $57.55 | 194,626 |
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 404
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 122,630 | $8.62 | 194,679 |
| Dec 18, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 617
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 195,079 | -- | 195,079 |
| Dec 17, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 617
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 195,438 | -- | 195,438 |
| Dec 13, 2023 |
Director, Bd. Co-Chair, President & CSO
Trans History: 617
|
Director, Bd. Co-Chair, President & CSO | Form 4 | Other acquisition or disposition | -- | -- | 196,848 |
| Mar 23, 2023 |
Director, President and Chief Scientific
Trans History: 617
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 400 | $810.30 | 196,848 |
| Mar 23, 2023 |
Director, President and Chief Scientific
Trans History: 617
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 700 | $806.47 | 197,248 |
| Mar 23, 2023 |
Director, President and Chief Scientific
Trans History: 617
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 47 | $805.55 | 197,948 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.